Title: From Discovery to Delivery: The Evolution of Surfactant and Neonatal Respiratory Care (PAS 2026) - Feb 25, 2026 - Abstract #2008.9; Pres time: Apr 25, 2026; 03:30 PM - 05:45 PM; Location: Poster Hall; "Early trials confirmed the efficacy of exogenous surfactant and highlighted advantages of animal-derived over synthetic preparations. Meta-analyses supported higher initial dosing of poractant alfa for improved outcomes. Large randomized controlled trials such as COIN and SUPPORT shifted practice toward CPAP-first with selective surfactant, reducing mechanical ventilation exposure."
Surfactant • Acute Respiratory Distress Syndrome • Respiratory Diseases
|